HEADER TRANSCRIPTION 06-OCT-17 6ENQ TITLE STRUCTURE OF HUMAN PPAR GAMMA LBD IN COMPLEX WITH LANIFIBRANOR TITLE 2 (IVA337) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR HORMONE RECEPTOR, PPARGAMMA MODULATOR, LANIFIBRANOR, KEYWDS 2 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR B.BOUBIA,O.POUPARDIN,M.BARTH,J.AMAUDRUT,P.BROQUA,M.TALLANDIER,D.ZEYER REVDAT 3 17-JAN-24 6ENQ 1 REMARK REVDAT 2 04-APR-18 6ENQ 1 SOURCE JRNL REMARK REVDAT 1 14-MAR-18 6ENQ 0 JRNL AUTH B.BOUBIA,O.POUPARDIN,M.BARTH,J.BINET,P.PERALBA,L.MOUNIER, JRNL AUTH 2 E.JACQUIER,E.GAUTHIER,V.LEPAIS,M.CHATAR,S.FERRY,A.THOURIGNY, JRNL AUTH 3 F.GUILLIER,J.LLACER,J.AMAUDRUT,P.DODEY,O.LACOMBE,P.MASSON, JRNL AUTH 4 C.MONTALBETTI,G.WETTSTEIN,J.M.LUCCARINI,C.LEGENDRE, JRNL AUTH 5 J.L.JUNIEN,P.BROQUA JRNL TITL DESIGN, SYNTHESIS, AND EVALUATION OF A NOVEL SERIES OF JRNL TITL 2 INDOLE SULFONAMIDE PEROXISOME PROLIFERATOR ACTIVATED JRNL TITL 3 RECEPTOR (PPAR) ALPHA / GAMMA / DELTA TRIPLE ACTIVATORS: JRNL TITL 4 DISCOVERY OF LANIFIBRANOR, A NEW ANTIFIBROTIC CLINICAL JRNL TITL 5 CANDIDATE. JRNL REF J. MED. CHEM. V. 61 2246 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29446942 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01285 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.8 REMARK 3 NUMBER OF REFLECTIONS : 29908 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4021 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 172 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ENQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1200006863. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 123 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32992 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06400 REMARK 200 FOR THE DATA SET : 16.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.34900 REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1PRG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NA CITRATE 0,9 M 1,2 - PROPANEDIOL 3,5 REMARK 280 % HEPES 0,1 M, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.44000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.44000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 196 REMARK 465 ILE A 197 REMARK 465 SER A 198 REMARK 465 SER A 199 REMARK 465 ASP A 200 REMARK 465 ILE A 201 REMARK 465 ASP A 202 REMARK 465 GLN A 203 REMARK 465 GLU A 259 REMARK 465 ASP A 260 REMARK 465 LYS A 261 REMARK 465 ILE A 262 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 LEU A 476 REMARK 465 TYR A 477 REMARK 465 GLU B 196 REMARK 465 ILE B 197 REMARK 465 SER B 198 REMARK 465 SER B 199 REMARK 465 ASP B 200 REMARK 465 ILE B 201 REMARK 465 ASP B 202 REMARK 465 GLN B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 GLY B 239 REMARK 465 LYS B 240 REMARK 465 THR B 241 REMARK 465 THR B 242 REMARK 465 ASP B 243 REMARK 465 LYS B 244 REMARK 465 ASP B 260 REMARK 465 LYS B 261 REMARK 465 ILE B 262 REMARK 465 LYS B 263 REMARK 465 PHE B 264 REMARK 465 LYS B 265 REMARK 465 HIS B 266 REMARK 465 ILE B 267 REMARK 465 THR B 268 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 LYS B 275 REMARK 465 LEU B 476 REMARK 465 TYR B 477 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 649 O HOH A 689 2.09 REMARK 500 O HOH A 618 O HOH A 692 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 207 -43.12 -179.36 REMARK 500 ASP A 243 177.88 49.74 REMARK 500 ASP A 251 -178.75 -172.82 REMARK 500 SER A 394 -70.81 -74.30 REMARK 500 GLU A 460 76.87 -112.49 REMARK 500 LYS A 474 79.08 -66.33 REMARK 500 MET B 257 23.73 -79.21 REMARK 500 ARG B 357 -175.45 -47.54 REMARK 500 LYS B 458 37.03 -94.91 REMARK 500 THR B 459 -61.04 -131.89 REMARK 500 THR B 461 -113.07 -147.71 REMARK 500 SER B 464 0.89 -64.84 REMARK 500 PRO B 467 -56.92 -29.29 REMARK 500 LYS B 474 -113.16 -79.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 239 LYS A 240 -63.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BJB A 501 DBREF 6ENQ A 196 477 UNP P37231 PPARG_HUMAN 224 505 DBREF 6ENQ B 196 477 UNP P37231 PPARG_HUMAN 224 505 SEQRES 1 A 282 GLU ILE SER SER ASP ILE ASP GLN LEU ASN PRO GLU SER SEQRES 2 A 282 ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR ASP SER SEQRES 3 A 282 TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS ALA ARG SEQRES 4 A 282 ALA ILE LEU THR GLY LYS THR THR ASP LYS SER PRO PHE SEQRES 5 A 282 VAL ILE TYR ASP MET ASN SER LEU MET MET GLY GLU ASP SEQRES 6 A 282 LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN GLU GLN SEQRES 7 A 282 SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY CYS GLN SEQRES 8 A 282 PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR GLU TYR SEQRES 9 A 282 ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP LEU ASN SEQRES 10 A 282 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ILE SEQRES 11 A 282 ILE TYR THR MET LEU ALA SER LEU MET ASN LYS ASP GLY SEQRES 12 A 282 VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR ARG GLU SEQRES 13 A 282 PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP PHE MET SEQRES 14 A 282 GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU SEQRES 15 A 282 GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE ALA VAL SEQRES 16 A 282 ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU ASN VAL SEQRES 17 A 282 LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU GLN ALA SEQRES 18 A 282 LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU SER SER SEQRES 19 A 282 GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR ASP LEU SEQRES 20 A 282 ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU GLN VAL SEQRES 21 A 282 ILE LYS LYS THR GLU THR ASP MET SER LEU HIS PRO LEU SEQRES 22 A 282 LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 B 282 GLU ILE SER SER ASP ILE ASP GLN LEU ASN PRO GLU SER SEQRES 2 B 282 ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR ASP SER SEQRES 3 B 282 TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS ALA ARG SEQRES 4 B 282 ALA ILE LEU THR GLY LYS THR THR ASP LYS SER PRO PHE SEQRES 5 B 282 VAL ILE TYR ASP MET ASN SER LEU MET MET GLY GLU ASP SEQRES 6 B 282 LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN GLU GLN SEQRES 7 B 282 SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY CYS GLN SEQRES 8 B 282 PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR GLU TYR SEQRES 9 B 282 ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP LEU ASN SEQRES 10 B 282 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ILE SEQRES 11 B 282 ILE TYR THR MET LEU ALA SER LEU MET ASN LYS ASP GLY SEQRES 12 B 282 VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR ARG GLU SEQRES 13 B 282 PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP PHE MET SEQRES 14 B 282 GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU SEQRES 15 B 282 GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE ALA VAL SEQRES 16 B 282 ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU ASN VAL SEQRES 17 B 282 LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU GLN ALA SEQRES 18 B 282 LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU SER SER SEQRES 19 B 282 GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR ASP LEU SEQRES 20 B 282 ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU GLN VAL SEQRES 21 B 282 ILE LYS LYS THR GLU THR ASP MET SER LEU HIS PRO LEU SEQRES 22 B 282 LEU GLN GLU ILE TYR LYS ASP LEU TYR HET BJB A 501 28 HETNAM BJB 4-[1-(1,3-BENZOTHIAZOL-6-YLSULFONYL)-5-CHLORO-INDOL-2- HETNAM 2 BJB YL]BUTANOIC ACID FORMUL 3 BJB C19 H15 CL N2 O4 S2 FORMUL 4 HOH *172(H2 O) HELIX 1 AA1 GLU A 207 PHE A 226 1 20 HELIX 2 AA2 THR A 229 GLY A 239 1 11 HELIX 3 AA3 ASP A 251 GLY A 258 1 8 HELIX 4 AA4 GLU A 276 ILE A 303 1 28 HELIX 5 AA5 GLY A 305 LEU A 309 5 5 HELIX 6 AA6 ASP A 310 LEU A 333 1 24 HELIX 7 AA7 SER A 342 GLY A 344 5 3 HELIX 8 AA8 ARG A 350 SER A 355 1 6 HELIX 9 AA9 PRO A 359 PHE A 363 5 5 HELIX 10 AB1 MET A 364 ASN A 375 1 12 HELIX 11 AB2 ALA A 376 GLU A 378 5 3 HELIX 12 AB3 ASP A 380 LEU A 393 1 14 HELIX 13 AB4 ASN A 402 HIS A 425 1 24 HELIX 14 AB5 GLN A 430 GLU A 460 1 31 HELIX 15 AB6 HIS A 466 LYS A 474 1 9 HELIX 16 AB7 SER B 208 PHE B 226 1 19 HELIX 17 AB8 THR B 229 LEU B 237 1 9 HELIX 18 AB9 ASP B 251 MET B 257 1 7 HELIX 19 AC1 VAL B 277 SER B 302 1 26 HELIX 20 AC2 GLY B 305 LEU B 309 5 5 HELIX 21 AC3 ASP B 310 ALA B 331 1 22 HELIX 22 AC4 SER B 342 GLY B 344 5 3 HELIX 23 AC5 ARG B 350 SER B 355 1 6 HELIX 24 AC6 MET B 364 ASN B 375 1 12 HELIX 25 AC7 ALA B 376 GLU B 378 5 3 HELIX 26 AC8 ASP B 380 LEU B 393 1 14 HELIX 27 AC9 ASN B 402 HIS B 425 1 24 HELIX 28 AD1 GLN B 430 LYS B 458 1 29 HELIX 29 AD2 HIS B 466 TYR B 473 1 8 SHEET 1 AA1 4 PHE A 247 ILE A 249 0 SHEET 2 AA1 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 AA1 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 AA1 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 AA2 4 PHE B 247 ILE B 249 0 SHEET 2 AA2 4 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 AA2 4 GLY B 338 ILE B 341 -1 N VAL B 339 O MET B 348 SHEET 4 AA2 4 MET B 334 ASN B 335 -1 N ASN B 335 O GLY B 338 CISPEP 1 LYS A 358 PRO A 359 0 -4.50 CISPEP 2 LYS B 358 PRO B 359 0 -3.83 SITE 1 AC1 12 LEU A 228 CYS A 285 ARG A 288 SER A 289 SITE 2 AC1 12 TYR A 327 LEU A 330 LEU A 333 VAL A 339 SITE 3 AC1 12 LEU A 340 GLU A 343 GLY A 344 HOH A 649 CRYST1 92.880 60.000 117.490 90.00 102.93 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010767 0.000000 0.002472 0.00000 SCALE2 0.000000 0.016667 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008733 0.00000